Literature DB >> 21944247

Direct effect of protein kinase C inhibitors on cardiovascular ion channels.

Youn Kyoung Son1, Da Hye Hong, Dae-Joong Kim, Amy L Firth, Won Sun Park.   

Abstract

Protein kinase C (PKC) is a central enzyme that modulates numerous biological functions. For this reason, specific PKC inhibitors/ activators are required to study PKC-related signaling mechanisms. To date, although many PKC inhibitors have been developed, they are limited by poor selectivity and nonspecificity. In this review, we focus on the nonspecific actions of PKC inhibitors on cardiovascular ion channels in addition to their PKC-inhibiting functions. The aim of this paper is to urge caution when using PKC inhibitors to block PKC function. This information may help to better understand PKC-related physiological/biochemical studies.

Mesh:

Substances:

Year:  2011        PMID: 21944247     DOI: 10.5483/bmbrep.2011.44.9.559

Source DB:  PubMed          Journal:  BMB Rep        ISSN: 1976-6696            Impact factor:   4.778


  5 in total

Review 1.  Advances in Immunosuppressive Agents Based on Signal Pathway.

Authors:  Zhiqing Xu; Ming Chu
Journal:  Front Pharmacol       Date:  2022-05-26       Impact factor: 5.988

Review 2.  PKC regulation of ion channels: The involvement of PIP2.

Authors:  Kirin D Gada; Diomedes E Logothetis
Journal:  J Biol Chem       Date:  2022-05-16       Impact factor: 5.486

3.  Regulation of the firing activity by PKA-PKC-Src family kinases in cultured neurons of hypothalamic arcuate nucleus.

Authors:  Xiao-Dong Sun; Anqi Wang; Peng Ma; Shan Gong; Jin Tao; Xian-Min Yu; Xinghong Jiang
Journal:  J Neurosci Res       Date:  2019-08-12       Impact factor: 4.164

4.  Identification of the novel substrates for caspase-6 in apoptosis using proteomic approaches.

Authors:  Jin Hwa Cho; Phil Young Lee; Woo-Chan Son; Seung-Wook Chi; Byoung Chul Park; Jeong-Hoon Kim; Sung Goo Park
Journal:  BMB Rep       Date:  2013-12       Impact factor: 4.778

5.  Novel AGLP-1 albumin fusion protein as a long-lasting agent for type 2 diabetes.

Authors:  Yong-Mo Kim; Sang Mee Lee; Hye-Shin Chung
Journal:  BMB Rep       Date:  2013-12       Impact factor: 4.778

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.